MIRA INFORM REPORT

 

 

Report Date :

27.07.2013

 

IDENTIFICATION DETAILS

 

Name :

PHARMAZELL (INDIA) PRIVATE LIMITED

 

 

Formerly Known As :

NOVEON DIAMALT PRIVATE LIMITED

 

 

Registered Office :

Plot No. B5 and B6, Madras Export Processing Zone, Tambaram, Chennai – 600045, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

22.09.1993

 

 

Com. Reg. No.:

18-025852

 

 

Capital Investment / Paid-up Capital :

Rs. 45.000 millions

 

 

CIN No.:

[Company Identification No.]

U24294TN1993PTC025852

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHED00550E

 

 

PAN No.:

[Permanent Account No.]

AAACD3338F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and providing of active pharmaceutical ingredients (API’s) and intermediates.

 

 

No. of Employees :

60 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (58)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 2800000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established partnership concern having a satisfactory track record. Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct and as per commitment.

 

The concern can be considered for normal business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Anantharam

Designation :

Finance Department

Contact No.:

91-44-22626262

Date :

23.07.2013

 

 

LOCATIONS

 

Registered Office / Factory :

Plot No. B5 and B6, Madras Export Processing Zone, Tambaram, Chennai – 600045, Tamilnadu, India

Tel. No.:

91-44-22626262

Fax No. :

Not Available

E-Mail :

premnkb@gmail.com

anantharam@pharmazell.com

Website :

www.pharmazell.com

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Govindaraj Ramakrishnan

Designation :

Managing Director

Address :

Plot -1511, T-5 Krishnan Nagar, Anna Nagar (West), Chennai - 600050

Date of Birth/Age :

12.12.1953

Date of Appointment :

01.04.2010

DIN No. :

00888254

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24294TN1993PTC025852

PHARMAZELL (INDIA) PRIVATE LIMITED

Managing director

01/04/2010

30/09/2002

-

Active

NO

2

U02423AP2007PTC071744

PHARMAZELL (VIZAG) PRIVATE LIMITED

Director

12/01/2007

12/01/2007

-

Active

NO

3

U24297AP2007PTC071494

PHARMAZELL R AND D (INDIA) PRIVATE LIMITED

Director

05/11/2007

05/11/2007

-

Under liquidation

NO

4

U85110TN1994PLC027417

BILLROTH HOSPITALS LIMITED

Director

30/05/2008

30/05/2008

-

Active

NO

 

 

Name :

Mr. Anant Dattatray Barbadikar

Designation :

Director

Address :

1-83-15/5, F. No.302, Sampath Chambers, MVP Colony, Sec-3, Double Road, Vishakapatnam – 530017, Andhra Pradesh, India

Date of Birth/Age :

02.01.1966

Date of Appointment :

30.09.2010

DIN No. :

01867501

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U02423AP2007PTC071744

PHARMAZELL (VIZAG) PRIVATE LIMITED

Managing director

11/09/2008

24/09/2007

-

Active

NO

2

U24294TN1993PTC025852

PHARMAZELL (INDIA) PRIVATE LIMITED

Director

30/09/2010

19/02/2010

-

Active

NO

3

U24297AP2007PTC071494

PHARMAZELL R & D (INDIA) PRIVATE LIMITED

Managing director

24/01/2011

01/12/2010

-

Under liquidation

NO

 

 

Name :

Mr. Oliver Valentin Bolzern

Designation :

Director

Address :

Nicklheim, Fichtenweg, 9 B, Raubling 83064, Switzerland

Date of Birth/Age :

14.12.1956

Date of Appointment :

08.02.2003

DIN No. :

01944621

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24294TN1993PTC025852

PHARMAZELL (INDIA) PRIVATE LIMITED

Director

08/02/2003

08/02/2003

-

Active

NO

2

U02423AP2007PTC071744

PHARMAZELL (VIZAG) PRIVATE LIMITED

Director

11/09/2008

10/01/2008

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Anantharam

Designation :

Finance Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2012

 

Names of Shareholders

 

No. of Shares

Pharmazell Beteiligungs Gmbh

 

200

Pharmazell Gmbh

 

449800

Total

 

450000

 

As on 29.09.2012

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and providing of active pharmaceutical ingredients (API’s) and intermediates.

 

 

Products :

Item Code No. (ITC Code)

Product Description

293090.05

L-Cysteine

 

 

Exports :

 

Products :

Finished Good

Countries :

·         Germany

Brazil

Argentina

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Credit

 

 

Purchasing :

Credit and Depend

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity *

Actual Production **

Amino Acid Products

In Metric Tonnes

NA

1000

331.996

Propafenone

In Metric Tonnes

NA

100

57.114

Others

In Metric Tonnes

NA

260

33.705

 

Note:

 

*On triple shift basis, as certified by the management and relied upon by the auditors. The installed capacity is subject to product mix and utilization of plant and machinery, which is common for different products.

 

**Production excludes the material processed on conversion basis.

 

GENERAL INFORMATION

 

No. of Employees :

60 (Approximately)

 

 

Bankers :

Indian Bank, Chennai, Tamilnadu, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

R Subramanian And Company

Chartered Accountant

Address :

New No. 6, Krishnaswamy Avenue, Luz, Mylapore, Chennai – 600004, Tamilnadu, India

Tel. No.:

91-44-24992261 / 24991347 / 24994231

Fax No.:

91-44-24991408

E-mail :

rs@rscompany.co.in

Website :

www.rscompany.co.in

PAN No. :

AAAFR0602F

 

 

Holding Company :

Pharmazell Gmbh

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs. 100/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

450000

Equity Shares

Rs. 100/- each

Rs. 45.000 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

45.000

45.000

(b) Reserves & Surplus

 

656.982

516.561

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

701.982

561.561

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

8.077

10.198

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

6.850

4.898

Total Non-current Liabilities (3)

 

14.927

15.096

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

42.167

46.996

(c) Other current liabilities

 

5.239

7.530

(d) Short-term provisions

 

24.333

21.691

Total Current Liabilities (4)

 

71.739

76.217

 

 

 

 

TOTAL

 

788.648

652.874

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

171.176

158.423

(ii) Intangible Assets

 

3.345

4.460

(iii) Capital work-in-progress

 

12.206

7.482

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.374

(e) Other Non-current assets

 

5.623

9.784

Total Non-Current Assets

 

192.350

180.523

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

93.510

73.395

(c) Trade receivables

 

427.614

358.064

(d) Cash and cash equivalents

 

57.978

28.432

(e) Short-term loans and advances

 

14.535

10.058

(f) Other current assets

 

2.661

2.402

Total Current Assets

 

596.298

472.351

 

 

 

 

TOTAL

 

788.648

652.874

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

45.000

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

410.809

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

455.809

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

0.000

DEFERRED TAX LIABILITIES

 

 

7.233

 

 

 

 

TOTAL

 

 

463.042

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

123.589

Capital work-in-progress

 

 

23.411

 

 

 

 

INVESTMENT

 

 

0.000

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

100.383

 

Sundry Debtors

 

 

254.072

 

Cash & Bank Balances

 

 

7.807

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

121.411

Total Current Assets

 

 

483.673

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

45.914

 

Other Current Liabilities

 

 

10.271

 

Provisions

 

 

111.446

Total Current Liabilities

 

 

167.631

Net Current Assets

 

 

316.042

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

463.042

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from Operations

894.142

666.893

 

 

 

Other Operating Revenue

0.693

18.830

 

 

 

Other Income

3.057

0.440

 

 

 

TOTAL                                     (A)

897.892

686.163

548.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

405.213

279.503

 

 

 

Employee benefit expense

85.719

69.725

 

 

 

Other Expenses

162.118

151.124

 

 

 

Increase/ (Decrease) in Finished Goods and WIP

12.925

2.683

 

 

 

TOTAL                                    

665.975

503.035

485.600

 

 

 

 

(Including

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

231.917

183.128

Depreciation)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

27.144

22.913

 

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX 

204.773

160.215

62.400

 

 

 

 

 

Less

TAX                                                                 

64.352

54.464

23.500

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

140.421

105.751

38.900

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

712.914

487.317

427.190

 

 

Conversion Charges

153.692

155.875

112.074

 

TOTAL EARNINGS

866.606

643.192

539.264

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Capital Goods

2.946

3.737

7.007

 

 

Raw Materials

302.593

198.357

178.241

 

 

Packing Materials

0.872

2.529

1.620

 

 

Stores and Spares

0.726

4.954

5.243

 

TOTAL IMPORTS

307.137

209.577

192.111

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

312.05

235.00

86.37

 

Particulars

 

 

 

31.03.2013

 

 

 

 

Sales Turnover (Approximately)

 

 

900.000

 

 

 

 

 

The above information has been parted by Mr. Anantharam (Finance Department)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

 

PAT / Total Income

(%)

15.64

15.41

7.10

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

22.90

24.02

NNA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

26.37

92.59

10.28

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.29

0.29

0.14

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

8.31

6.20

2.89

 

 

LOCAL AGENCY FURTHER INFORMATION

 

INDEX OF CHARGES : NO CHARGES EXIST FOR COMPANY

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last four years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

COURSE OF BUSINESS AND OUTLOOK

 

During the year, progress has continued in the company's performance. The company had achieved a turnover of Rs.884.900 millions as compared to the turnover of Rs. 683.400 millions in the previous  corresponding year .The profit after tax stood at Rs. 140.400 millions as compared to Rs. 105.700 millions in the previous year.

 

 

FIXED ASSETS

 

v                  Tangible Assets

Land

Buildings

Plant and Machinery

Furniture and Fixtures

Office Equipments

Computer Equipments

Vehicles

v                 Intangible Assets

Computer Software


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.58.91

UK Pound

1

Rs.90.68

Euro

1

Rs.78.22

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

58

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.